Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling.

MLA

Liu, Chen, et al. “Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 1, Jan. 2021, pp. 342–54. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-20-2718.

APA

Liu, C., Lu, H., Wang, H., Loo, A., Zhang, X., Yang, G., Kowal, C., Delach, S., Wang, Y., Goldoni, S., Hastings, W. D., Wong, K., Gao, H., Meyer, M. J., Moody, S. E., LaMarche, M. J., Engelman, J. A., Williams, J. A., Hammerman, P. S., … Hao, H.-X. (2021). Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(1), 342–354. https://doi.org/10.1158/1078-0432.CCR-20-2718

Chicago

Liu, Chen, Hengyu Lu, Hongyun Wang, Alice Loo, Xiamei Zhang, Guizhi Yang, Colleen Kowal, et al. 2021. “Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27 (1): 342–54. doi:10.1158/1078-0432.CCR-20-2718.